Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide

K Mizumoto, RJ Rothman and JL Farber

Department of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

The mechanism by which etoposide, a topoisomerase II inhibitor, killed replicating mouse L929 fibroblasts was investigated. Etoposide at 10 microM killed 70% of the cells within 4 days, a result that was accompanied by DNA fragmentation. A characteristic "ladder" pattern of DNA fragmentation was confirmed by agarose gel electrophoresis. Simultaneous exposure of the cells to 10 microM etoposide plus 1 microM cycloheximide reduced both the extent of cell killing and the fragmentation of DNA. Delayed addition of cycloheximide protected cells only if cycloheximide was added 1-6 hr after exposure to etoposide. When added 6-24 hr after treatment with etoposide, cycloheximide lost the ability to protect cells. Cell growth was completely inhibited by either etoposide or cycloheximide. Furthermore, DNA synthesis was inhibited by either etoposide or cycloheximide within 6 hr. Protein synthesis, however, was not inhibited by etoposide. Thus, the ability of cycloheximide to protect cells correlated with inhibition of protein synthesis, rather than inhibition of DNA synthesis. A 1-hr exposure to 2.5 mM N-methyl-N-nitrosourea similarly inhibited DNA synthesis within 6 hr. without affecting protein synthesis. However, no loss of viability accompanied N-methyl-N-nitrosourea treatment. Thus, an imbalance between protein synthesis and DNA synthesis cannot explain the cell killing by etoposide. H-7, a protein kinase C inhibitor, prevented the cell killing and DNA fragmentation, whereas aurintricarboxylic acid, an endonuclease inhibitor, reduced the extent of DNA fragmentation but did not have an effect on cell killing. The data document that the killing of replicating mouse fibroblasts by etoposide represents an example of programmed cell death (apoptosis) that depends on protein synthesis. Although protein synthesis is required during the first 24 hr of exposure to etoposide, cell death is delayed until several days later.

Volume 46, Issue 5, pp. 890-895, 11/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. Vasconsuelo, L. Milanesi, and R. Boland 17{beta}-Estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway J. Endocrinol., February 1, 2008; 196(2): 385 - 397. [Abstract] [Full Text] [PDF]

				K. Heon Seo, H.-M. Ko, H.-A Kim, J.-H. Choi, S. Jun Park, K.-J. Kim, H.-K. Lee, and S.-Y. Im Platelet-Activating Factor Induces Up-regulation of Antiapoptotic Factors in a Melanoma Cell Line through Nuclear Factor-{kappa}B Activation. Cancer Res., May 1, 2006; 66(9): 4681 - 4686. [Abstract] [Full Text] [PDF]

				N. O. Karpinich, M. Tafani, R. J. Rothman, M. A. Russo, and J. L. Farber The Course of Etoposide-induced Apoptosis from Damage to DNA and p53 Activation to Mitochondrial Release of Cytochrome c J. Biol. Chem., May 3, 2002; 277(19): 16547 - 16552. [Abstract] [Full Text] [PDF]

				E. Raderschall, K. Stout, S. Freier, V. Suckow, S. Schweiger, and T. Haaf Elevated Levels of Rad51 Recombination Protein in Tumor Cells Cancer Res., January 1, 2002; 62(1): 219 - 225. [Abstract] [Full Text] [PDF]

				E. Raderschall, A. Bazarov, J. Cao, R. Lurz, A. Smith, W. Mann, H.-H. Ropers, J. M. Sedivy, E. I. Golub, E. Fritz, et al. Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis J. Cell Sci., January 1, 2002; 115(1): 153 - 164. [Abstract] [Full Text] [PDF]

				J. G. Pastorino, M. Tafani, and J. L. Farber Tumor Necrosis Factor Induces Phosphorylation and Translocation of BAD through a Phosphatidylinositide-3-OH Kinase-dependent Pathway J. Biol. Chem., July 2, 1999; 274(27): 19411 - 19416. [Abstract] [Full Text] [PDF]

				G. M. Kasof, L. Goyal, and E. White Btf, a Novel Death-Promoting Transcriptional Repressor That Interacts with Bcl-2-Related Proteins Mol. Cell. Biol., June 1, 1999; 19(6): 4390 - 4404. [Abstract] [Full Text] [PDF]

				T. Haaf, E. Raderschall, G. Reddy, D. C. Ward, C. M. Radding, and E. I. Golub Sequestration of Mammalian Rad51-Recombination Protein into Micronuclei J. Cell Biol., January 11, 1999; 144(1): 11 - 20. [Abstract] [Full Text] [PDF]

				M. T. Osborn and T. C. Chambers Role of the Stress-activated/c-Jun NH2-terminal Protein Kinase Pathway in the Cellular Response to Adriamycin and Other Chemotherapeutic Drugs J. Biol. Chem., November 29, 1996; 271(48): 30950 - 30955. [Abstract] [Full Text] [PDF]

				J. G. Pastorino, G. Simbula, K. Yamamoto, P. A. Glascott Jr., R. J. Rothman, and J. L. Farber The Cytotoxicity of Tumor Necrosis Factor Depends on Induction of the Mitochondrial Permeability Transition J. Biol. Chem., November 22, 1996; 271(47): 29792 - 29798. [Abstract] [Full Text] [PDF]